{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:45:41Z","timestamp":1783388741722,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["NO 2022-02044"],"award-info":[{"award-number":["NO 2022-02044"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2020-01616"],"award-info":[{"award-number":["2020-01616"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012829","name":"Guangdong Provincial Hospital of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["BJ2022KY11"],"award-info":[{"award-number":["BJ2022KY11"]}],"id":[{"id":"10.13039\/100012829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012829","name":"Guangdong Provincial Hospital of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["YN2018QL08"],"award-info":[{"award-number":["YN2018QL08"]}],"id":[{"id":"10.13039\/100012829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82004205"],"award-info":[{"award-number":["82004205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2500200"],"award-info":[{"award-number":["2021YFC2500200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020TQ0137"],"award-info":[{"award-number":["2020TQ0137"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M672741"],"award-info":[{"award-number":["2020M672741"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ijantimicag.2022.106691","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T07:40:23Z","timestamp":1668152423000},"page":"106691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Piperacillin\/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5073-9848","authenticated-orcid":false,"given":"Guobin","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixia","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1434-6366","authenticated-orcid":false,"given":"Yue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9875-2419","authenticated-orcid":false,"given":"Qingqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongqiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bicheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozhong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5491-3460","authenticated-orcid":false,"given":"David W","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan Fan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2022.106691_bib0001","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","article-title":"Acute kidney injury","volume":"394","author":"Ronco","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0002","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(13)60647-9","article-title":"Acute kidney injury: an increasing global concern","volume":"382","author":"Lameire","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1611391","article-title":"Epidemiology of acute kidney injury in critically ill children and young adults","volume":"376","author":"Kaddourah","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0004","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0005","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.2215\/CJN.02140215","article-title":"Epidemiology and clinical correlates of AKI in Chinese hospitalized adults","volume":"10","author":"Xu","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0006","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/jama.2014.12923","article-title":"Prevalence of antimicrobial use in US acute care hospitals, May\u2013September 2011","volume":"312","author":"Magill","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0007","article-title":"Association of acute kidney injury with concomitant vancomycin and piperacillin\/tazobactam treatment among hospitalized children","volume":"171","author":"Downes","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02658-18","article-title":"Incidence of acute kidney injury in critically ill patients receiving vancomycin with concomitant piperacillin-tazobactam, cefepime, or meropenem","volume":"63","author":"Blevins","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01572-19","article-title":"The association of acute kidney injury with the concomitant use of vancomycin and piperacillin\/tazobactam in children: a systematic review and meta-analysis","volume":"63","author":"Kalligeros","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0010","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s40265-017-0764-7","article-title":"The whole price of vancomycin: toxicities, troughs, and time","volume":"77","author":"Jeffres","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0011","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1111\/bcp.15429","article-title":"Risk factors for vancomycin-associated acute kidney injury: a systematic review and meta-analysis","volume":"88","author":"Kim","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0012","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/phar.1918","article-title":"Acute kidney injury in patients treated with IV beta-lactam\/beta-lactamase inhibitor combinations","volume":"37","author":"Rutter","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0013","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijantimicag.2018.11.002","article-title":"Impact of piperacillin\/tazobactam on nephrotoxicity in patients with Gram-negative bacteraemia","volume":"53","author":"Hall","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0014","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1681\/ASN.2018121223","article-title":"Piperacillin\/tazobactam and antibiotic-associated acute kidney injury in critically ill children","volume":"30","author":"Joyce","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s15010-020-01480-x","article-title":"Evaluation of the risk of acute kidney injury with the use of piperacillin\/tazobactam among adult critically ill patients","volume":"48","author":"Saad","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0016","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/cid\/ciz668","article-title":"Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection: a multisite retrospective study","volume":"70","author":"Babich","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0017","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0018","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0019","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000635","article-title":"Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial","volume":"2","author":"Jensen","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00871-17","article-title":"Influence of beta-lactam infusion strategy on acute kidney injury","volume":"61","author":"Cotner","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0023","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11739-020-02287-2","article-title":"Acute kidney injury and vancomycin\/piperacillin\/tazobactam in adult patients: a systematic review","volume":"15","author":"Ciarambino","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0024","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/cid\/ciw811","article-title":"Systematic review and meta-analysis of acute kidney injury associated with concomitant vancomycin and piperacillin\/tazobactam","volume":"64","author":"Hammond","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0025","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","article-title":"Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review","volume":"68","author":"Elyasi","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0026","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s40264-019-00846-x","article-title":"Evaluating renal stress using pharmacokinetic urinary biomarker data in critically ill patients receiving vancomycin and\/or piperacillin-tazobactam: a secondary analysis of the multicenter Sapphire study","volume":"42","author":"Kane-Gill","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0027","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/phar.1442","article-title":"Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam","volume":"34","author":"Burgess","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0028","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/cid\/ciz1189","article-title":"Piperacillin-tazobactam added to vancomycin increases risk for acute kidney injury: fact or fiction?","volume":"71","author":"Avedissian","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0029","doi-asserted-by":"crossref","first-page":"F1293","DOI":"10.1152\/ajprenal.00013.2012","article-title":"A role for the organic anion transporter OAT3 in renal creatinine secretion in mice","volume":"302","author":"Vallon","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0030","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2014.66","article-title":"Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat","volume":"86","author":"Lepist","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0031","series-title":"The Sanford guide to antimicrobial therapy","first-page":"192","author":"Sanford","year":"2011"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0032","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2017.12.037","article-title":"OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam","volume":"537","author":"Wen","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0033","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpneph0076","article-title":"Drug-associated renal dysfunction and injury","volume":"2","author":"Choudhury","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0034","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000513742","article-title":"Nephrotoxicity from vancomycin combined with piperacillin-tazobactam: a comprehensive review","volume":"52","author":"Blair","year":"2021","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0035","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s00134-022-06811-0","article-title":"Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study","volume":"48","author":"Miano","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0036","doi-asserted-by":"crossref","first-page":"e1579","DOI":"10.1093\/cid\/ciaa1902","article-title":"Risk of acute kidney injury and Clostridioides difficile infection with piperacillin\/tazobactam, cefepime, and meropenem with or without vancomycin","volume":"73","author":"Lee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0037","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00002018-200730040-00002","article-title":"Systematic review of piperacillin-induced neutropenia","volume":"30","author":"Scheetz","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijantimicag.2022.106691_bib0038","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922002175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922002175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:27:53Z","timestamp":1778549273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857922002175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0924857922002175"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106691","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Piperacillin\/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106691"}}